Welcome to our dedicated page for Infusystem Hld news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on Infusystem Hld stock.
InfuSystem Holdings Inc (INFU) delivers essential medical equipment and outpatient care services across North America, specializing in infusion therapy solutions for oncology, pain management, and chronic care. This page provides investors and healthcare professionals with timely updates on the company's operational milestones and strategic initiatives.
Access consolidated INFU news including earnings announcements, regulatory filings, and partnership developments. Our repository features press releases related to medical device innovations, service expansions, and leadership updates – all critical for assessing the company's position in the durable medical equipment sector.
Key content categories include quarterly financial results, biomedical service enhancements, and coverage of INFU's dual-platform strategy balancing patient care with device lifecycle management. Bookmark this page to monitor INFU's progress in bridging clinical and home-based healthcare delivery.
InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national health care service provider, has announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. The company will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results.
InfuSystem operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy businesses, and Device Solutions, which supports Patient Services and focuses on direct payer clients. The company provides outpatient care solutions for durable medical equipment manufacturers and health care providers, with a focus on clinic-to-home healthcare for complex treatments.
InfuSystem will present at the Sidoti Small Cap Virtual Investor Conference on June 12, 2024, at 8:30 a.m. Eastern Time. The conference will feature presentations from CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance. Investors can access the live webcast and replay on InfuSystem's website. Additionally, the management will host virtual one-on-one meetings throughout the day. InfuSystem, based in Rochester Hills, Michigan, provides outpatient care for durable medical equipment through two main platforms: Patient Services and Device Solutions. The company operates several Centers of Excellence in the USA and Canada.
InfuSystem, a national healthcare service provider, announced a $20 million stock repurchase program authorized by its Board of Directors. This program extends through June 30, 2026, and replaces the previous authorization expiring June 30, 2024, under which 550 thousand shares were repurchased for $6.2 million. The new program highlights confidence in the company’s operations, financial strength, and future outlook, allowing flexible share repurchases under favorable conditions. CEO Richard DiIorio emphasized the company’s commitment to strategic investments for sustainable growth while considering opportunistic buybacks.
InfuSystem reported record net revenues of $32.0 million in the first quarter of 2024, representing a 5% growth from the prior year. The gross profit increased by 10%, with a gross margin of 51.5%. Adjusted EBITDA decreased by 9% compared to the prior year. The company's liquidity totaled $45.4 million as of March 31, 2024.
InfuSystem Holdings, Inc. (NYSE American: INFU) will report first quarter 2024 financial results on May 9, 2024. The company will conduct a conference call at 9:00 a.m. Eastern Time to discuss the results. InfuSystem is a leading national health care service provider, offering outpatient care for durable medical equipment manufacturers and health care providers.
FAQ
What is the current stock price of Infusystem Hld (INFU)?
What is the market cap of Infusystem Hld (INFU)?
